海外の治験の状況「濾胞性リンパ腫」での検索結果
1540件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma
- Follicular Non-Hodgkin's Lymphoma Refractory
- Austria, Belgium, France, Germany, Greece, Ireland, Italy, Portugal, Spain, United Kingdom
- 2018-06-14
Recruiting
- Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma
- Lymphoma
- United States
- 2018-03-09
Recruiting
- Personalized Risk Stratification Model of Follicular Lymphoma Patients
- Follicular Lymphoma
- Italy, Switzerland
- 2018-02-06
Not Recruiting
- Short CHemo RadioImmunotherapy in Follicular Trial of 90Y Ibritumomab tiuxetan (ZevalinTM) as therapy for first and second relapse in Follicular Lymphoma - SCHRIFT
- Follicular Lymphoma First and second relapse of Follicular Lymphoma grade 1, 2, 3a.
- United Kingdom
- 2007-06-14
Not Recruiting
- Phase III multicentric IIL study, three randomized arms (R-CVP vs R-CHOP vs R-FM),for treatment of patients with stage II-IV follicular lymphoma
- Stage II-IV Follicular Lymphoma br>MedDRA version: 14.1 Level: PT Classification code 10016897 Term: Follicle centre lymphoma diffuse small cell lymphoma recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Italy
- 2007-03-13
Not recruiting
- A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma
- Lymphoma, Follicular
- Argentina, Australia, Brazil, Canada, Czech Republic, Denmark, Ecuador, Finland, France, Israel, Italy, Korea, Republic of, Mexico, Norway, Peru, Poland, Russian Federation, Slovakia, Spain, Sweden, Switzerland, United Kingdom
- 2009-06-16
Not recruiting
- Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma
- Lymphoma;Lymphoma;Lymphoma;Lymphoma
- United States
- 2009-05-18
Not recruiting
- VELCADE® Plus Rituximab in Non Hodgkin's Follicular Lymphoma
- Non Hodgkin's Follicular Lymphoma
- Italy
- 2010-12-28
Not recruiting
- Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
- Lymphoma, Follicular
- Argentina, Czech Republic, France, Italy, Spain, Switzerland, United Kingdom, United States
- 2010-11-26